|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Austrian Cholesterol Screening And Treatment II (ACT II)|
|Study Start Date:||May 2009|
|Study Completion Date:||December 2010|
|Primary Completion Date:||December 2010 (Final data collection date for primary outcome measure)|
Participants in whom LDL-C target levels have not been achieved and for whom ezetimibe therapy has been chosen.
Ezetimibe was not mandatory and was prescribed as per routine prescription by physician.